Monitoring lidocaine single-crystal dissolution by ultraviolet imaging.

Dissolution critically affects the bioavailability of Biopharmaceutics Classification System class 2 compounds. When unexpected dissolution behaviour occurs, detailed studies using high information content technologies are warranted. In the present study, an evaluation of real-time ultraviolet (UV) imaging for conducting single-crystal dissolution studies was performed. Using lidocaine as a model compound, the aim was to develop a setup capable of monitoring and quantifying the dissolution of lidocaine into a phosphate buffer, pH 7.4, under stagnant conditions. A single crystal of lidocaine was placed in the quartz dissolution cell and UV imaging was performed at 254 nm. Spatially and temporally resolved mapping of lidocaine concentration during the dissolution process was achieved from the recorded images. UV imaging facilitated the monitoring of lidocaine concentrations in the dissolution media adjacent to the single crystals. The concentration maps revealed the effects of natural convection due to density gradients on the dissolution process of lidocaine. UV imaging has great potential for in vitro drug dissolution testing.

[1]  Sergei G. Kazarian,et al.  “Chemical Photography” of Drug Release , 2003 .

[2]  K. P. Nott.  Magnetic resonance imaging of tablet dissolution. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[4]  W. Lindberg,et al.  Design and characterization of a new miniaturized rotating disk equipment for in vitro dissolution rate studies. , 2008, Journal of pharmaceutical sciences.

[5]  P. Missel,et al.  Impact of Density Gradients on Flow-Through Dissolution in a Cylindrical Flow Cell , 2006, Pharmaceutical development and technology.

[6]  A. Healy,et al.  Hydrodynamic and Species Transfer Simulations in the USP 4 Dissolution Apparatus: Considerations for Dissolution in a Low Velocity Pulsing Flow , 2010, Pharmaceutical Research.

[7]  Karsten Mäder,et al.  Pharmaceutical applications of magnetic resonance imaging (MRI). , 2005, Advanced drug delivery reviews.

[8]  H. Metz,et al.  Benchtop-NMR and MRI--a new analytical tool in drug delivery research. , 2008, International journal of pharmaceutics.

[9]  A. Guerri,et al.  2‐(Diethyl­amino)‐N‐(2,6‐dimethyl­phenyl)acetamide, a low‐temperature redetermination , 2007 .

[10]  H. Burt,et al.  Dissolution anisotropy in nickel sulfate α hexahydrate crystals , 1979 .

[11]  S. Larsen,et al.  Real-Time UV Imaging of Nicotine Release from Transdermal Patch , 2010, Pharmaceutical Research.

[12]  R. Ristic,et al.  Dissolution kinetics of paracetamol single crystals. , 2002, International journal of pharmaceutics.

[13]  Michael J. Cima,et al.  Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Mark McAllister,et al.  Dynamic dissolution: a step closer to predictive dissolution testing? , 2010, Molecular pharmaceutics.

[15]  Alex Avdeef,et al.  Miniaturized Rotating Disk Intrinsic Dissolution Rate Measurement: Effects of Buffer Capacity in Comparisons to Traditional Wood’s Apparatus , 2008, Pharmaceutical Research.

[16]  Jaap van der Weerd,et al.  Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests. , 2005, Journal of pharmaceutical sciences.

[17]  John N. Sherwood,et al.  Dissolution kinetics of single crystals of α‐lactose monohydrate , 2002 .

[18]  G. Amidon,et al.  Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.

[19]  P. Unwin,et al.  New strategies for probing crystal dissolution kinetics at the microscopic level , 1995 .

[20]  Alex Avdeef,et al.  Powder Dissolution Method for Estimating Rotating Disk Intrinsic Dissolution Rates of Low Solubility Drugs , 2009, Pharmaceutical Research.

[21]  Anne Marie Healy,et al.  Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Sergei G. Kazarian,et al.  Simultaneous FTIR Spectroscopic Imaging and Visible Photography to Monitor Tablet Dissolution and Drug Release , 2008, Pharmaceutical Research.

[23]  H. Chan,et al.  Dissolution studies of hexamethylmelamine , 1993 .

[24]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[25]  Allan S. Jones,et al.  Microstructural Analysis of Porous Composite Materials: Dynamic Imaging of Drug Dissolution and Diffusion Through Porous Matrices , 2008, The AAPS Journal.

[26]  S. Larsen,et al.  In Vitro Assessment of Lidocaine Release from Aqueous and Oil Solutions and from Preformed and in Situ Formed Aqueous and Oil Suspensions. Parenteral Depots for Intra-Articular Administration , 2008 .

[27]  A. Wahlén,et al.  Lidocaine Base and Hydrochloride , 1985 .